mifepristone has been researched along with Cardiomyopathies in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Di, W; Ding, G; Huang, M; Liu, J; Lv, S; Lv, Y; Qi, H; Sheng, Y; Yu, J; Zhou, S | 1 |
| Fuller, PJ; Funder, JW; Morgan, J; Rickard, AJ; Young, MJ | 1 |
2 other study(ies) available for mifepristone and Cardiomyopathies
| Article | Year |
|---|---|
11β-hydroxysteroid dehydrogenase type 1 inhibitor attenuates high-fat diet induced cardiomyopathy.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 1; Animals; Animals, Newborn; Calcium Signaling; Cardiomyopathies; Diet, High-Fat; Glucose Tolerance Test; Male; Mifepristone; Mineralocorticoid Receptor Antagonists; Myocytes, Cardiac; Palmitic Acid; Rats; Rats, Wistar; Receptors, Glucocorticoid; Receptors, Mineralocorticoid; Spironolactone | 2018 |
Does glucocorticoid receptor blockade exacerbate tissue damage after mineralocorticoid/salt administration?
Topics: Animals; Biomarkers; Blood Pressure; Cardiomegaly; Cardiomyopathies; Coronary Vessels; Desoxycorticosterone; Drug Administration Schedule; Eplerenone; Fibrosis; Hormone Antagonists; Male; Mifepristone; Myocardium; Organ Size; Oxidative Stress; Rats; Rats, Sprague-Dawley; Receptors, Glucocorticoid; Signal Transduction; Sodium Chloride; Spironolactone; Vasculitis | 2007 |